Genetic Polymorphisms Affecting Elimination of Heavy Metals

Polymorphism and Heavy Metals

Genetic Polymorphisms Affecting Elimination of Heavy Metals

Why your genes can make mercury, lead, and arsenic detox easier (or harder)—and how to personalize your plan

When people ask me why two clients can do “the same” heavy metal detox and get very different results, my short answer is: biology beats protocol. Your genes—especially the ones that handle binding, moving, and exporting metals—quietly determine how well chelators work in your body.

In this article, I’ll walk you through the key genetic polymorphisms that influence chelation efficacy, what the science actually shows, and how I translate this into practical, layperson-friendly personalization. I’ll also share where natural protocols like Dr. Georgiou’s HMD™ can fit, and how to think about “precision detox” without turning your life into a lab project.

The big idea (in plain English)

Chelation isn’t just about swallowing a pill and “flushing” metals. It’s a three-step relay:

  1. Mobilize the metal (often from tissues)
  2. Bind it safely (so it doesn’t re-stick somewhere worse)
  3. Export it (mostly through the kidneys, sometimes bile)

Genes can influence each step: how much metal gets mobilized, how sticky your internal binding proteins are, and how efficiently the kidneys and liver pump the metal (or metal-chelator complex) out.

In practice, I see four gene families come up again and again:

  • Metallothioneins (MTs) and glutathione (GSH) pathways (binding and protection)
  • Drug/metal transporters (kidney & liver pumps that export the “payload”)
  • Metal-specific metabolism genes (e.g., arsenic methylation)
  • Metal-interaction genes like ALAD (lead), sometimes APOE (mercury neurotoxicity)

Let’s get specific.

1) Transporter genes: the “pumps” that make-or-break export

Most chelators aim to get metals into a form your kidneys can excrete. That last mile depends on transporter proteins in kidney tubules and bile canaliculi.

ABCC2 (MRP2): a key efflux pump for mercury

Multiple human studies link ABCC2 (MRP2) polymorphisms to differences in urinary inorganic mercury (Hg²⁺) excretion—i.e., how effectively your body can pump Hg out once it’s bound or conjugated. Think of MRP2 as a gate: if your variant is less active, you may retain more mercury and respond more slowly to detox.

What this means for chelation: If MRP2 is a bottleneck, I go slower, support bile/kidney flow aggressively (hydration, fiber, bitters), and use gentler mobilization so we don’t “traffic jam” metals.

OAT1 / OAT3 (SLC22A6 / SLC22A8): HMD needs these

The chelator HMD uses renal organic anion transporters OAT1 and OAT3 to cross into kidney cells and facilitate excretion. If your OAT activity is low, HMD protocols may be less efficient (or need adjusting).

What this means: In people with signs of sluggish OAT function (or relevant polymorphisms), I often prioritize kidney support first, consider alternate dosing schedules, and sometimes favor chelators or binders that rely less on rapid OAT-mediated shuttling.

NaDC3 (SLC13A3): HMD uses this door

HMD concentrates in the renal cortex where most of the heavy metals are eliminated. If NaDC3 function varies, you could see different HMD handling and excretion—and therefore different response curves.

What this means: When someone “doesn’t move” much metal on HMD despite textbook dosing, I consider NaDC3/SLC13A3 variability plus the basics (hydration, urine pH, mineral status).

2) Glutathione and metallothionein genes: your internal “chelators”

Glutathione system (GCLC, GCLM, GSTM1/GSTT1/GSTP1)

Glutathione (GSH) conjugation is central to moving metals—especially methylmercury—toward excretion. Polymorphisms in GSTs (GSTM1/GSTT1 deletions and GSTP1 variants) and rate-limiting enzymes for GSH synthesis (GCLC/GCLM) have been associated with higher mercury levels and/or altered toxicity risk in cohorts and reviews. Practically, a GST-null genotype can mean slower conjugation and potentially a “slower chelation responder.”

What this means: I support GSH upstream (sulfur-rich foods; NAC; minerals like selenium, zinc) and move cautiously on mobilization. Sometimes I stagger chelators with phases that emphasize antioxidant repletion.

Metallothioneins (MT1/MT2 family)

Metallothioneins are small, cysteine-rich proteins that bind metals like zinc, copper—and importantly cadmium and mercury—acting as rapid-response buffers. Reviews highlight MTs as dynamic “metal sponges,” and emerging data link MT gene variants (e.g., MT1/MT2) to differences in metal handling and toxicity risk. If your MTs are less responsive, mobilized metals may not be sequestered as safely inside cells while awaiting export.

What this means: I ensure adequate zinc/selenium, consider protein status, and keep mobilization mild at first. People with suspected MT vulnerabilities often do better with longer, lower-intensity detox phases.

3) Metal-specific genes: arsenic, lead, and mercury examples

Arsenic: AS3MT drives methylation and excretion

Your liver converts inorganic arsenic into mono- and dimethylated forms for urinary excretion. Variants in AS3MT consistently predict how efficiently you methylate arsenic, which in turn affects body burden and risk. If methylation is inefficient, chelation can still help—but I’ll expect a slower decline in total arsenic unless we support one-carbon metabolism (folate, B12, choline, betaine).

Lead: ALAD changes lead kinetics (and chelation profiles)

ALAD (δ-aminolevulinic acid dehydratase) polymorphisms change how lead partitions between blood and bone. People with certain ALAD variants show different blood lead levels at similar exposures—and that can influence how much “drop” you see from a given chelation round because blood lead is the main thing chelators reduce first.

Mercury: ABCC2 + GSTs (again), and sometimes APOE

We’ve already met ABCC2 (MRP2) and the GSTs; together they shape mercury conjugation and export pathways. There’s also evidence that APOE genotype (notably ε4) may modify susceptibility to mercury neurotoxicity, which matters for how aggressively we mobilize mercury near the CNS. I’m more cautious with ε4 carriers: slower pacing, antioxidant emphasis, and making sure exit routes are wide open.

So… do these genes change how chelators work?

Short answer: yes, mechanistically—and often clinically—though the human chelator-by-genotype trials we all want are still scarce. Here’s how I think about the big agents:

Natural binders & protocols (e.g., HMD™ + Chlorella + Lavage)

Why genetics matter here too: HMD™ leans on natural mobilizers and binders (e.g., cilantro/coriander, chlorella growth factor and chlorella) and drainage support. Your GST/MT capacity and transporter activity still shape how smoothly metals move and exit. I’ve seen GST-null individuals benefit from a longer “priming” phase (sulfur foods, NAC, selenium, zinc) before ramping up; they generally report fewer detox symptoms and steadier progress.

Evidence context: The strongest genotype-chelation data exist for mercury excretion and transporter/GST variants, arsenic methylation (AS3MT), and lead kinetics (ALAD). While the HMD™ research base includes internal and practitioner reports, much of the genotype-specific literature comes from academic studies on pathways (MRP2/ABCC2, GSTs, AS3MT, etc.), not branded protocols.

I integrate that pathway science to personalize natural detox programs on a case-by-case basis.

How I personalize chelation with genetics (without overcomplicating your life)

You don’t need a $1,000 gene panel to get started. Here’s the framework I use:

Step 1 — Baseline “phenotype” checks (no genetics yet)

  • Exposure pattern: fish intake, work/home exposures, dental history.
  • Clinical labs: kidney & liver function; minerals (zinc, selenium, magnesium); CBC; homocysteine (methylation proxy).
  • Speciation where it matters: urinary arsenic speciation (is it mostly arsenobetaine from seafood, or inorganic/methylated forms that track with risk?).
  • Air/water basics: filter quality, dust control—because if exposure continues, genes won’t save you.

Step 2 — Choose the on-ramp based on risk & resilience

  • Sensitive or “reactive” folks (fatigue, MCS, history of strong Herx): longer priming phase—GSH support (foods + NAC), minerals, fiber, bitters, sauna/hydration, sleep.
  • Robust folks: shorter priming, cautious chelation start.

Step 3 — Add targeted genetics if progress stalls or risk is high

  • ABCC2/MRP2 (mercury export), GSTM1/T1/P1 (conjugation), AS3MT (arsenic methylation), ALAD (lead), and sometimes APOE (mercury neuro-susceptibility).
  • What I do with results:
    • MRP2 “low” or GST-null: slow mobilization; extra bile/kidney support; more fiber; smaller, more frequent doses.
    • AS3MT inefficient: emphasize methylation nutrients (folate, B12, choline/betaine) alongside chelation.
    • ALAD variant: expect different blood lead dynamics; manage expectations and duration.
    • APOE-ε4: mercury detox in smaller steps with strong antioxidant cover.

Step 4 — Pick the tool and pacing

  • Natural protocol (e.g., HMD™ + Chlorella + Lavage): start here for many clients—especially those with low resilience—because it binds gently and supports drainage. Genetics mainly informs pacing and cofactors (GSH, minerals).
  • I normally recommend a 90-day detox protocol called 90-DAY HMD ULTIMATE DETOX.

Step 5 — Monitor signals that matter

  • Symptoms and stamina (sleep, energy, headaches, skin, bowels).
  • Objective markers: periodic urinary metals (creatinine-normalized), arsenic speciation if relevant, plus basic labs to ensure kidneys/liver stay happy.
  • Course-correct: increase spacing, rotate binders, or extend priming if symptoms flare.

Where HMD™ fits in a genetics-aware detox

I like HMD™ (with Organic Chlorella and LAVAGE support) as a foundation protocol when I want steady progress with minimal drama. If someone’s GST capacity looks limited (by history or genotype), I’ll run a longer preparatory phase (sulfur foods, NAC, selenium, zinc, magnesium) and introduce HMD™ slowly.

The normal adult dose of HMD is 45 drops x 3 times daily, but with people with chronic diseases I have been known to drop this to one drop x 3 times daily and increase by one drop daily until reaching the recommended dose.

If MRP2/ABCC2 looks like a pinch-point, I’m extra fussy about hydration, fiber, bitters, and bowel regularity so the exit routes don’t choke. The goal isn’t speed; it’s traction you can sustain.

(Note: formal genotype-by-HMD outcome studies haven’t been published to my knowledge; I’m applying pathway science—MRP2, GSTs, MTs, etc.—to personalize natural programs.)

Quick science snapshots you can trust

A friendly bottom line

If chelation hasn’t worked for you—or worked but came with rough side effects—it doesn’t mean detox “isn’t your thing.” It probably means your biology needs a different rhythm:

  • Prime first: minerals, protein, sulfur foods, NAC, selenium, hydration, fiber, bitters, sleep.
  • Support the pumps: if MRP2/ABCC2 looks weak, slow down and widen the exits (kidneys/bile/bowels).
  • Match the metal: AS3MT for arsenic; ALAD for lead; GSTs/APOE nuance mercury.
  • Use natural protocols (like HMD™) when you need a gentler lane, and bring in pharmaceutical chelators when the terrain calls for them.

I’m a big believer in precision detox: less heroics, more fit. Your genes don’t dictate your destiny—but they do tell us how to make chelation work with your body, not against it.

Disclaimer: This article is educational and not medical advice. Always work with a qualified clinician when using chelators, especially if you have kidney/liver disease, are pregnant/breastfeeding, or are on interacting medications.

Important Links

Picture of Dr George

Dr George

Dr. George J. Georgiou, Ph.D., N.D., D.Sc (AM), M.Sc., B.Sc, is a world-renowned expert in the field of holistic medicine and detoxification. As the inventor of the highly acclaimed Dr. Georgiou's Heavy Metal Detox Protocol, and the main product, HMD™ (Heavy Metal Detox), he has revolutionized the approach to natural heavy metal detoxification. With over 35 years of experience in natural medicine, he has authored 23 books, including the comprehensive guide 'Curing the Incurable with Holistic Medicine,' which offers invaluable insights and over 700 scientific references. Dr. Georgiou's groundbreaking work is sought after by individuals and practitioners worldwide through his Da Vinci Institute of Holistic Medicine and Da Vinci Holistic Health Center based in Larnaca, Cyprus.
Share the Post:

Join the Discussion

Your email address will not be published.


Related Posts

HEAVY METALS & LIFESTYLE
Dr George

Men’s Sexual Health and Heavy Metals

Men’s Sexual Health and Heavy Metals How Heavy Metals Wreak Havoc on Male Sexual Function Let’s get into the mechanics. Sexual health, especially things like getting and maintaining an erection,

Read More »
Sexual health and heavy metals
HEAVY METALS AND DISEASES
Dr George

Heavy Metals and Sexual Health

Heavy Metals & Sexual Health How Toxins Like Lead, Arsenic & Mercury Wreck Sexual Health If your libido has taken a mysterious nosedive or things just aren’t working the way

Read More »
Shopping cart0
There are no products in the cart!
Continue shopping
0